— Informatics-guided Innovative Medicine Discovery
● Immunotherapy for Cancer and Autoimmune Diseases
At EnnovaBio we are exploring multiple targeting modalities to discover novel modulators of highly validated immune checkpoint pathways. Besides immuno-oncology, we are taking similar approaches in developing innovative therapeutics for autoimmune and chronic inflammatory diseases.
● Targeted Therapy for Cancer Cell Resistance
A major limitation of targeted therapies is cancer cell drug resistance. Powered by human genetics, translational research and our proprietary informatics platform, we focus on targeting key signaling pathways to reduce the development of cancer cell resistance.